Background

  • 7 years of post-doctoral academic research at two Max-Planck-Insitututes and at the University of Victoria, Canada
  • 4 years at Janssen, J&J
    • Responsible for all preclinical licensing and collaborations leading a department
    • Part of international team for clinical licensing project
    • Streamlined processes and internal client information
    • Brought new technology to Janssen
  •  

  • 5 years at WITA Proteomics
    • Lead a biotech of 15 people as CEO
    • Organized company and set-up world-leading proteomics platform
    • Created seven digit € revenue with services and collaborations
    • Went through investment crises and found acquirer

 

  • 3 years at Devgen
    • Lead BD Pharma, reported to the CEO and board, was part of IPO
    • Created seven digit € revenue with services and collaborations
    • Lead the company from a service focus to a product focus
    • Negotiated multimillion dollar pharma licensing opportunity

 

  • 5 years at Galantos Pharma
    • Co-Managing Director, CBO, reported to the board
    • Financing the company for product development
    • Lead the company from idea to clinical product with CSO
    • Negotiated multimillion dollar licensing opportunities

 

  • since 2003 working as Interim Manager and Consultant, since 2012 on a full time basis
    • Technology benchmarking, - costing, successfull partnering, project support
    • Technology matchmaking
    • Successfull biotech company sale
    • Organizational and process optimization in emerging companies

 

  • Fluent in English and Dutch, German mother tongue, some French and Spanish

Customer satisfaction is our most valued reward!